07:00 , Jul 2, 2012 |  BC Week In Review  |  Company News

AmDerma, Oculus deal

Oculus granted AmDerma exclusive rights to develop and commercialize compounds using Oculus' Microcyn technology for dermatology indications, including acne. AmDerma will have rights to the compounds in the U.S. and India, with a right of...
07:00 , Jul 4, 2011 |  BC Week In Review  |  Company News

AmDerma, Oculus deal

AmDerma exercised an option to license Oculus' Microcyn technology for a yet to be determined formulation to treat acne. The parties said they expect to finalize the terms of the license agreement within the next...
08:00 , Feb 21, 2011 |  BC Week In Review  |  Company News

AmDerma Pharmaceuticals LLC, Oculus deal

Oculus granted AmDerma an option to license Oculus' Microcyn technology for $500,000 for a yet to be determined formulation to treat acne. If AmDerma exercises its option, Oculus will receive an undisclosed upfront payment, and...